SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-066288
Filing Date
2022-03-04
Accepted
2022-03-04 17:06:17
Documents
14
Period of Report
2022-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d313986d8ka.htm   iXBRL 8-K/A 29618
2 EX-99.1 d313986dex991.htm EX-99.1 5798
6 GRAPHIC g313986g02d35.jpg GRAPHIC 3868
  Complete submission text file 0001193125-22-066288.txt   174652

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20220217.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20220217_lab.xml EX-101.LAB 19444
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20220217_pre.xml EX-101.PRE 12137
8 EXTRACTED XBRL INSTANCE DOCUMENT d313986d8ka_htm.xml XML 3820
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39122 | Film No.: 22715113
SIC: 2834 Pharmaceutical Preparations